Axcella Health (AXLA) Tops Q2 EPS by 8c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/29/2026

1. NOW
2. MSFT
3. GOOGL
4. FTNT
5. EBAY
6. TENB
7. BIIB
8. CMG
9. KLAC
10. ETSY

Go back to Axcella Health (AXLA) Tops Q2 EPS by 8c

Axcella Reports Positive Top-Line Data from AXA1665-002 and Second Quarter Financial Results

August 5, 2020 7:30 AM EDT

Top-line data from AXA1665-002 show dose dependent improvements in markers of cognitive function and amino acid metabolism; both AXA1665 doses safe and well tolerated for 12 Weeks; plan to initiate Phase 2 clinical trial under IND in 1H 2021 Reported positive top-line data for AXA1125, Axcellas NASH product candidate, with clinically relevant reductions in liver fat content, insulin resistance and fibroinflammation; plan to initiate Phase 2b clinical trial under IND in 1H 2021 Completed follow-on equity offering, raising approximately $60 million in gross proceeds Company to hold conference call today at... More